Sana Biotechnology Files 8-K with Financials
Ticker: SANA · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1770121
Sentiment: neutral
Topics: financial-statements, exhibits
TL;DR
Sana Bio filed an 8-K with financials on 6/23/25 - nothing major, just routine.
AI Summary
On June 23, 2025, Sana Biotechnology, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating routine corporate activity rather than a specific material event. No new material agreements, executive changes, or significant financial transactions were disclosed in this particular filing.
Why It Matters
This filing provides updated financial information and exhibits for Sana Biotechnology, Inc., which is standard for public companies and may be reviewed by investors for operational context.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report containing financial statements and exhibits, with no indication of new material events or risks.
Key Players & Entities
- Sana Biotechnology, Inc. (company) — Registrant
- June 23, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing by Sana Biotechnology, Inc.?
The primary purpose of this 8-K filing is to report financial statements and exhibits as of June 23, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is June 23, 2025.
What is the state of incorporation for Sana Biotechnology, Inc.?
Sana Biotechnology, Inc. is incorporated in Delaware.
What is the principal executive office address for Sana Biotechnology, Inc.?
The principal executive office address is 188 East Blaine Street, Suite 400, Seattle, Washington 98102.
What is the telephone number for Sana Biotechnology, Inc.?
The registrant's telephone number, including area code, is (206) 701-7914.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Sana Biotechnology, Inc. (SANA).